SUPRIYA LIFESCIENCE LTD (SUPRIYA) financials — quarterly results, P&L, cash flow, balance sheet, shareholding

Supriya Lifescience is engaged in the manufacturing of Active pharmaceutical ingredients (APIs). As of March 31, 2021, the company produces 38 APIs focused on diverse therapeutic segments such as antihistamine, analgesic, anaesthetic, vitamin, anti-asthmatic and anti-allergic.[1]

SUPRIYAUpdated 1 Sept 2026, 21:45

Supriya Lifescience Ltd

Market Cap

₹6,455Cr.

Current Price

₹803

High / Low

₹1,086/546

Stock P/E

32.5

ROE19.1%
ROCE25.1%
Book Value₹149
Face Value₹2.00
Dividend Yield0.12%

About

Supriya Lifescience is engaged in the manufacturing of Active pharmaceutical ingredients (APIs). As of March 31, 2021, the company produces 38 APIs focused on diverse therapeutic segments such as antihistamine, analgesic, anaesthetic, vitamin, anti-asthmatic and anti-allergic.[1]

Quarterly results

Last reported quarters₹ Cr.

Profit & loss

Annual statement₹ Cr.

Shareholding pattern

As of Jun 2026%

Shareholding trend

Ownership over time%

Balance sheet

Assets & liabilities₹ Cr.

Cash flows

Operating, investing & financing₹ Cr.

Key ratios

Historical financial ratios
CategoryMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days99927960697967717097
Inventory Days1138577130206172234140205229
Days Payable1211121101301459113098129159
Cash Conversion Cycle91644561130160171114146167
Working Capital Days-69-50-5-4028117168157144147
ROCE %14%37%50%60%43%19%22%27%25%

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 1 September 2026 at 21:45


Designed & Shipped by Harshit Bansal